Primary Human Hepatocytes-Laden Scaffolds for the Treatment of Acute Liver Failure

Scientists proposed the use of gelatin-hyaluronic acid (Gel-HA) scaffolds seeded with primary human hepatocytes for the treatment of liver failure. They first optimized the composition using Gel-HA hydrogels, looking for the mechanical properties closer to the human liver and determining HepG2 cells functionality.